Santhera Pharmaceuticals Holding AG (SWX:SANN)

SWX:SANN Balance Sheet

Financials in millions CHF. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	18.4	40.93	30.37	1.35	21.21	12.41
Cash & Short-Term Investments	18.4	40.93	30.37	1.35	21.21	12.41
Cash Growth	11.56%	34.76%	2144.64%	-93.62%	70.88%	-60.42%
Accounts Receivable	11.2	9.06	0.44	0.44	0.96	2.32
Other Receivables	-	4.83	1.72	0.65	0.97	2.16
Receivables	11.2	13.89	2.16	1.09	1.94	4.49
Inventory	26.03	17.53	1.81	0.11	0.43	0.48
Prepaid Expenses	0.44	0.37	0.32	0.51	1.07	0.34
Other Current Assets	2.74	3.1	-	-	-	-
Total Current Assets	58.8	75.81	34.66	3.07	24.64	17.72
Property, Plant & Equipment	2.31	2.57	0.58	1.01	1.32	1.9
Long-Term Investments	0.25	0.25	0.42	0.44	0.47	0.55
Other Intangible Assets	66.44	68.95	73.97	59.21	64.6	67.67
Long-Term Deferred Tax Assets	-	-	-	0	0.09	0.84
Other Long-Term Assets	2.97	4.91	-	-	-	-
Total Assets	130.77	152.49	109.63	63.73	91.12	88.69
Accounts Payable	24.44	5.75	3.56	3.9	2.41	3.8
Accrued Expenses	16.58	19.35	9.57	10.85	9.71	8.65
Short-Term Debt	-	-	-	22.13	1.49	10.6
Current Portion of Long-Term Debt	6.85	6.4	20.94	-	13.88	-
Current Portion of Leases	0.59	0.55	0.57	0.62	0.61	0.77
Current Income Taxes Payable	0.04	0.14	0.18	0.55	0.27	0.06
Current Unearned Revenue	0.09	0.06	-	-	-	1.13
Other Current Liabilities	9.19	13.9	10.97	11.36	4.42	4.07
Total Current Liabilities	57.78	46.14	45.79	49.41	32.78	29.07
Long-Term Debt	32.12	31.73	-	21.08	25.8	57.88
Long-Term Leases	1.66	1.94	0.04	0.61	1.2	1.93
Long-Term Unearned Revenue	1.85	1.93	-	-	-	-
Pension & Post-Retirement Benefits	2.96	7.67	3.86	1.84	4.79	6.17
Other Long-Term Liabilities	36.96	35.38	-	34.47	25.21	-
Total Liabilities	133.33	124.79	49.69	107.41	89.79	95.04
Common Stock	1.36	1.34	1.26	0.75	54.61	19.43
Retained Earnings	-653.53	-614.69	-572.72	-627.5	-556.43	-500.9
Treasury Stock	-0.06	-0.07	-0.13	-0.09	-5.02	-1.58
Comprehensive Income & Other	649.67	641.11	631.53	583.16	508.17	476.7
Shareholders' Equity	-2.56	27.7	59.94	-43.69	1.33	-6.35
Total Liabilities & Equity	130.77	152.49	109.63	63.73	91.12	88.69
Total Debt	41.22	40.62	21.55	44.44	42.98	71.17
Net Cash (Debt)	-22.83	0.31	8.82	-43.08	-21.77	-58.76
Net Cash Growth	-	-96.54%	-	-	-	-
Net Cash Per Share	-1.88	0.03	0.81	-7.07	-6.37	-44.12
Filing Date Shares Outstanding	12.93	12.79	11.32	6.59	4.96	1.81
Total Common Shares Outstanding	12.93	12.79	11.32	6.59	4.96	1.81
Working Capital	1.02	29.67	-11.14	-46.35	-8.14	-11.35
Book Value Per Share	-0.20	2.17	5.30	-6.63	0.27	-3.50
Tangible Book Value	-69	-41.25	-14.02	-102.89	-63.27	-74.03
Tangible Book Value Per Share	-5.33	-3.22	-1.24	-15.62	-12.76	-40.83
Machinery	-	1.46	1.35	1.46	1.82	1.92
Leasehold Improvements	-	1.48	1.48	1.5	1.54	1.63

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.